Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Airway product recalls weigh down on CareFusion and Smiths

This article was originally published in Clinica

Executive Summary

The US FDA has given CareFusion's recall of its Avea ventilator the most serious classification. The company initiated the Class I action in September when it discovered a potential defect in the ventilator that could cause it to activate a false alarm and stop ventilating, which, in turn, could lead to patient injury or death if left unnoticed. Devices affected by the recall were manufactured between 1 March 2009 and 30 June 2011.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098345

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel